SimpleFixRx Investors | FinalFixRx GLP/GIP Nebulizer
FinalFixRx • GLP/GIP Nebulizer

First-to-Market, Needle-Free GLP/GIP Nebulizer — Built for Scale

SimpleFixRx is launching FinalFixRx: a smart, pharmacy-integrated nebulizer system designed to deliver GLP/GIP therapies via fine mist — offering a patient-friendly alternative to injections. We are raising capital to accelerate production, commercialization, and regulatory milestones ahead of the early-2026 launch.

Target Raise: $5M Launch: Early 2026 Device + Refills

A differentiated, needle-free delivery platform with recurring revenue and strong consumer appeal — built on a proven DTC engine.

Category Leadership

First-to-market GLP/GIP nebulizer delivery designed for comfort, discretion, and adherence — positioned to capture surging demand.

Scalable Unit Economics

Device sales + refill subscriptions; pharmacy-integrated operations and telehealth alignment to streamline onboarding and compliance.

De-Risked Launch

Leverages SimpleFixRx’s existing patient base, marketing engine, and provider network to accelerate market penetration.

FinalFixRx delivers GLP/GIP therapies via a smart nebulizer system; the companion app manages dosing, adherence, and outcomes reporting. Commercial model combines device margin with high-frequency cartridge revenue.

  • Go-to-Market: DTC with physician oversight; targeted B2B (clinics/weight-management brands) for scale.
  • Regulatory: FDA device pathway plus compliant pharmacy dispensing for refills; roadmap to expanded indications.
  • Use of Funds: Inventory, marketing, regulatory, team hires, and data infrastructure to support rapid scale.

Raise Snapshot

  • Target: $5,000,000
  • Use: 50% marketing, 30% inventory & production, 20% regulatory & team
  • Structure: Preferred equity / SAFE (flexible for strategic capital)
  • Milestones: Pilot completion, presale, national launch (2026)

A concise, visual overview of the problem, solution, market size, roadmap, and financial outlook.

Download Teaser to share with partners and ICs.

Access detailed financials, regulatory roadmap, clinical references, supply chain documentation, and commercial plans.

  • 5-year financial model with scenarios
  • Regulatory & quality documentation
  • Supply, licensing & pharmacy agreements
  • Market research & benchmarking
  • Pilot design, outcomes tracking plan

Request Access

Please include your firm, fund size, healthcare focus, and timeline.

Name

Thank you for your interest in this unique investment opportunity.

Data Room

Access the full investor data room, including the detailed deck, financial model, regulatory roadmap, and supporting documentation.

Open Data Room
Next Steps

Meet the Team • Review the Model • Join the Round

© 2025 SimpleFixRx Investors. All rights reserved.

info@simplefixrx-investors.com

This website and the materials contained herein are provided for informational purposes only. The information does not constitute an offer to sell or a solicitation of an offer to buy securities. Any offering of securities will be made only to a limited number of qualified investors in accordance with Rule 506(b) of Regulation D under the Securities Act of 1933. Access to additional information is restricted to pre-qualified investors by invitation only.

Scroll to Top